Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy

European Journal of Pediatrics

Volumn 156, Issue 7, 1997, Pages 562-564

  Lam, C W ^a,c   Lau, C H ^a   Williams, J C ^b   Chan, Y W ^a   Wong, L J C ^b  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

MELAS syndrome; Mitochondrial encephalomyopathy; Mitochondrial mutation; Valproate

Indexed keywords

MITOCHONDRIAL DNA; VALPROIC ACID;

ARTICLE; BRAIN DISEASE; CASE REPORT; CONVULSION; GENETIC COUNSELING; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MITOCHONDRIAL MYOPATHY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SCHOOL CHILD; STROKE;

ANTICONVULSANTS; CHILD; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MALE; MELAS SYNDROME; OXIDATIVE PHOSPHORYLATION; PEDIGREE; VALPROIC ACID;

EID: 0030758778     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050663     Document Type: Article

References (18)

1. Chabrol B, Mancini J, Chretien D, Rustin P, Munnich A, Pinsard N (1994) Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 153:133-135
2. Ciafaloni E, Ricci E, Shanske S et al. (1992) MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 31:391-398
3. De Stefano N, Matthews PM, Ford B et al. (1995) Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45:1193-1198
4. Goto Y, Horai S, Matsuoka T et al. (1992) Mitochondial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42:545-550
5. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 384:651-653
6. Haas R, Stumpf DA, Parks JK, Eguren L (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31:1473-1476
7. Honeycutt D, Callahan K, Rutledge L, Evans B (1992) Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Neurology 42:666-667
8. Kobayashi Y, Morishita H, Sugiyama N et al. (1987) Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome. J Pediatr 110:223-227
9. Lam CW, Jain K, Chan KY, Silva DK, Chan YW, Wong LJC (1995) Diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes in a Chinese family by PCR restriction enzyme analysis. J Clin Pathol Mol Pathol 48:M 285-288
10. Leao M (1995) Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency. Neurology 45:593-594
11. Pavlakis SG, Phillips PC, DiMauro S, DeVivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:484-488
12. 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 42:2147-2152
13. 3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol 43:644-647
14. Ponchaut S, Van Hoof F, Veitch K (1995) Valproate and cytochrome c oxidase deficiency. Eur J Pediatr 154:79
15. Rumbach L, Warter JM, Rendon A, Marescaux C, Micheletti G, Waksman A (1983) Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. J Neurol Sci 61:471-523
16. Rumbach L, Mutet C, Cremel G et al. (1986) Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies. Mol Pharmacol 30:270-273
17. Schapira AH, Cooper JN (1994) Inborn and induced defects of the mitochondrial respiratory chain. Biochem Soc Trans 22:996-1001
18. Walker UA, Byrne E (1995) The therapy of respiratory chain encephalomyopathy: a critical review of the past and current perspective. Acta Neurol Scand 92:273-280